DNA methylation status in glioblastomas, with MGMT values above 10% (10–50% and >50%), correlated with an age of patients over 50 years (p = 0.016), incomplete treatment (p = 0.030), and a lower resectability rate (p = 0.034). This evidence concerns the gene MGMT and glioblastoma.